Baird Financial Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.66M Sell
5,380
-4,705
-47% -$1.46M ﹤0.01% 1142
2026
Q2
$2.82M Buy
10,085
+5,966
+145% +$1.57M ﹤0.01% 970
2026
Q1
$1.1M Sell
4,119
-78
-2% -$21.1K ﹤0.01% 1238
2025
Q4
$1.05M Sell
4,197
-13,246
-76% -$3.52M ﹤0.01% 1233
2025
Q3
$5.01M Buy
17,443
+8,795
+102% +$2.36M 0.01% 736
2025
Q2
$2.27M Buy
8,648
+4,892
+130% +$1.19M ﹤0.01% 977
2025
Q1
$874K Sell
3,756
-29
-0.8% -$7.04K ﹤0.01% 1220
2024
Q4
$868K Sell
3,785
-452
-11% -$104K ﹤0.01% 1218
2024
Q3
$947K Sell
4,237
-5,353
-56% -$1.18M ﹤0.01% 1191
2024
Q2
$1.95M Sell
9,590
-29,772
-76% -$6.06M ﹤0.01% 966
2024
Q1
$8.6M Sell
39,362
-32,763
-45% -$7.22M 0.02% 514
2023
Q4
$16.4M Sell
72,125
-2,463
-3% -$517K 0.04% 353
2023
Q3
$15M Sell
74,588
-2,488
-3% -$525K 0.04% 350
2023
Q2
$18.6M Buy
77,076
+64,277
+502% +$14.5M 0.05% 315
2023
Q1
$2.94M Buy
12,799
+233
+2% +$55.8K 0.01% 768
2022
Q4
$2.96M Sell
12,566
-7,618
-38% -$1.73M 0.01% 743
2022
Q3
$4.13M Sell
20,184
-772
-4% -$184K 0.01% 618
2022
Q2
$4.91M Buy
20,956
+1,499
+8% +$372K 0.01% 582
2022
Q1
$5.13M Sell
19,457
-169,911
-90% -$46.5M 0.01% 607
2021
Q4
$59.5M Sell
189,368
-1,855
-1% -$535K 0.14% 174
2021
Q3
$53.8M Buy
191,223
+2,548
+1% +$747K 0.14% 180
2021
Q2
$52M Buy
188,675
+2,028
+1% +$538K 0.14% 180
2021
Q1
$47.6M Buy
186,647
+2,968
+2% +$693K 0.13% 183
2020
Q4
$37.4M Buy
183,679
+73,628
+67% +$14.8M 0.11% 211
2020
Q3
$20.7M Buy
110,051
+52,022
+90% +$9.6M 0.07% 262
2020
Q2
$9.6M Buy
58,029
+41,361
+248% +$6.66M 0.04% 352
2020
Q1
$2.11M Buy
16,668
+3,056
+22% +$513K 0.01% 672
2019
Q4
$2.3M Sell
13,612
-28,947
-68% -$4.86M 0.01% 729
2019
Q3
$7.15M Buy
42,559
+2,821
+7% +$479K 0.03% 424
2019
Q2
$6.87M Hold
39,738
– – 0.03% 434
2019
Q1
$2.42M Buy
15,822
+1,322
+9% +$190K 0.01% 607
2018
Q4
$1.83M Sell
14,500
-1,077
-7% -$168K 0.01% 660
2018
Q3
$2.7M Buy
15,577
+612
+4% +$108K 0.02% 592
2018
Q2
$2.69M Buy
14,965
+87
+0.6% +$15.3K 0.02% 586
2018
Q1
$2.41M Sell
14,878
-3,004
-17% -$514K 0.02% 593
2017
Q4
$2.85M Sell
17,882
-2,958
-14% -$455K 0.02% 537
2017
Q3
$3.15M Sell
20,840
-1,793
-8% -$278K 0.02% 511
2017
Q2
$3.49M Sell
22,633
-10,464
-32% -$1.49M 0.03% 478
2017
Q1
$4.75M Sell
33,097
-168,256
-84% -$23.2M 0.04% 407
2016
Q4
$25.8M Sell
201,353
-177,686
-47% -$23M 0.22% 136
2016
Q3
$52.1M Sell
379,039
-2,941
-0.8% -$403K 0.47% 46
2016
Q2
$49.8M Buy
381,980
+39,884
+12% +$5M 0.46% 50
2016
Q1
$40.1M Sell
342,096
-7,424
-2% -$829K 0.38% 69
2015
Q4
$43.2M Buy
349,520
+31,098
+10% +$3.73M 0.43% 56
2015
Q3
$34.5M Sell
318,422
-5,643
-2% -$679K 0.37% 77
2015
Q2
$39.3M Hold
324,065
– – 0.39% 79

Other funds holding LH

Baird Financial Group's LH Position: Q3 2026 in Review

Baird Financial Group reduced its Labcorp (LH) stake by 47% in Q3 2026, selling an estimated $1.46M and leaving 5,380 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Baird Financial Group first reported a position in LH in Q2 2015 and has held it in 46 quarters since. The position peaked at $59.5M in Q4 2021. 1,095 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Baird Financial Group held 5,380 shares of Labcorp worth $1.66M as of Q3 2026.
  • Baird Financial Group sold 4,705 Labcorp shares in Q3 2026, an estimated $1.46M.
  • Labcorp made up ﹤0.01% of Baird Financial Group's portfolio in Q3 2026, its #1142 holding.
  • Baird Financial Group first reported a position in Labcorp in Q2 2015 and has held it in 46 quarters since.
  • Baird Financial Group's Labcorp position peaked at $59.5M in Q4 2021.
  • 1,095 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Baird Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.